The Latest Breaking News on Pharma

The U.S. Drug Enforcement Administration is closing two of its offices in China, a move that comes even as the agency struggles to disrupt the flow of precursor chemicals from the country that have fueled a fentanyl epidemic

The drugmaker said its injections were 89 percent more effective than its own Truvada

Moderna stock is plunging Thursday after the COVID-19 vaccine maker announced plans to drastically cut its R&D spending to focus on new product approvals.

J&J CEO explained that the new drug-price negotiation law threatens development of new drugs, according to Bloomberg.

The NHS was forced to spend over £80m a year on hydrocortisone tablets after the price was rigged

The peak body for GPs has hit out at a NSW government plan to let pharmacies treat more health conditions to take pressure off doctors.

The healthcare sector is set for robust growth, driven by surging demand for quality treatments, a growing patient base, breakthroughs in biopharma, and supportive policies. Therefore, investors could consider undervalued pharmaceutical stocks like Merck & Co. (MRK), Pfizer (PFE), and Cigna (CI) with significant upside potential. Read more.

Nearly five years after COVID-19, a new analysis by The Associated Press shows that U.S. regulators are struggling to address a massive backlog of uninspected pharmaceutical plants

U.S. health inspectors are still struggling to address a massive backlog of pharmaceutical plants that went uninspected during disruptions caused by COVID-19

Pinellas Suncoast Transit Authority in Florida takes proactive steps to address opioid crisis by training employees and installing Narcan kits at terminals.

The lifecycle of AMD's new (but still unannounced) GPU continues, and now we're seeing the low-end version move in shipping manifests.